These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22306098)

  • 41. Clostridium difficile in goats and sheep in Slovenia: characterisation of strains and evidence of age-related shedding.
    Avberšek J; Pirš T; Pate M; Rupnik M; Ocepek M
    Anaerobe; 2014 Aug; 28():163-7. PubMed ID: 24960532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trial watch: Phase III success for novel Clostridium difficile antibiotic.
    Nat Rev Drug Discov; 2010 Apr; 9(4):260. PubMed ID: 20357795
    [No Abstract]   [Full Text] [Related]  

  • 43. Antimicrobial resistance in Clostridium difficile.
    Huang H; Weintraub A; Fang H; Nord CE
    Int J Antimicrob Agents; 2009 Dec; 34(6):516-22. PubMed ID: 19828299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial susceptibility and resistance mechanisms of clinical Clostridium difficile from a Chinese tertiary hospital.
    Dong D; Zhang L; Chen X; Jiang C; Yu B; Wang X; Peng Y
    Int J Antimicrob Agents; 2013 Jan; 41(1):80-4. PubMed ID: 23148985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
    Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
    Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abdominal aortic aneurysm secondary to infection with Pseudomonas aeruginosa: a rare cause of mycotic aneurysm.
    Dick J; Tiwari A; Menon J; Hamilton G
    Ann Vasc Surg; 2010 Jul; 24(5):692.e1-4. PubMed ID: 20409680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of Clostridium difficile in the environment in a rural community in Zimbabwe.
    Simango C
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1146-50. PubMed ID: 16698054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.
    Bessaleli E; Scheinfeld N
    Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Clostridium difficile disease in patients not responding to metronidazole.
    Kapoor S
    J Infect; 2008 May; 56(5):394-5. PubMed ID: 18410968
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.
    Baines SD; Noel AR; Huscroft GS; Todhunter SL; O'Connor R; Hobbs JK; Freeman J; Lovering AM; Wilcox MH
    J Antimicrob Chemother; 2011 Jul; 66(7):1537-46. PubMed ID: 21504940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early infection of hip joint prosthesis by Clostridium difficile in an HIV-1 infected patient.
    Brassinne L; Rodriguez-Villalobos H; Jonckheere S; Dubuc JE; Yombi JC
    Anaerobe; 2014 Jun; 27():96-9. PubMed ID: 24705255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection.
    Venugopal AA; Johnson S
    Clin Infect Dis; 2012 Feb; 54(4):568-74. PubMed ID: 22156854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycotic aortic aneurysm infected by Clostridium septicum--a case history.
    Hurley L; Howe K
    Angiology; 1991 Jul; 42(7):585-9. PubMed ID: 1863018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
    Mathur T; Kumar M; Barman TK; Kumar GR; Kalia V; Singhal S; Raj VS; Upadhyay DJ; Das B; Bhatnagar PK
    J Antimicrob Chemother; 2011 May; 66(5):1087-95. PubMed ID: 21393140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of slowly resolving enteritis caused by Clostridium difficile].
    Zoppi G; Vinco A; Cinquetti M; Barbato G; Luciano A
    Pediatr Med Chir; 1995; 17(5):459-60. PubMed ID: 8685005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infected abdominal aortic aneurysm due to Morganella morganii: CT findings.
    Kwon OY; Lee JS; Choi HS; Hong HP; Ko YG
    Abdom Imaging; 2011 Feb; 36(1):83-5. PubMed ID: 20352211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macrocyclic antibiotics: a novel class of drug for the treatment of Clostridium difficile infection.
    Blondeau JM
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):9-11. PubMed ID: 22142153
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.